Cargando…
Durvalumab/elasomeran: Immune thrombocytopenia: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184370/ http://dx.doi.org/10.1007/s40278-022-17034-2 |
Ejemplares similares
-
Elasomeran: Immune thrombocytopenia: case report
Publicado: (2022) -
Elasomeran: Immune thrombocytopenia: case report
Publicado: (2022) -
Elasomeran: Immune-mediated thrombocytopenia and myocarditis: case report
Publicado: (2022) -
AZD-1222/elasomeran: Immune thrombocytopenia and exacerbation of immune thrombocytopenia: 23 case reports
Publicado: (2022) -
Elasomeran/tozinameran: Severe immune thrombocytopenia: 2 case reports
Publicado: (2022)